Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline-Results From a Randomized Controlled Clinical Trial
Resumen
Palabras clave
Trastorno depresivo mayor; Tratamiento antiinflamatorio; Citocina
Citación recomendada
Simon MS, Burger B, Weidinger E, Arteaga-Henríquez G, Zill P, Musil R, et al. Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline-Results From a Randomized Controlled Clinical Trial. Front Psychiatry. 2021 Sep 27;12:615261.
Audiencia
Professionals
Usar este identificador para citar y/o enlazar este documento
https://hdl.handle.net/11351/7480Este elemento aparece en las siguientes colecciones
- HVH - Articles científics [2972]
- VHIR - Articles científics [1201]
El ítem tiene asociados los siguientes ficheros de licencia: